Updates in Lung Cancer Management

Milwaukee, WI US
August 20, 2022

This one day symposium will raise and address challenging questions in current clinical practice for thoracic oncology. Topics include updates in perioperative therapy, treatment of KRAS mutated NSCLC, managing challenging immunotherapy toxicities,  and the role of telemedicine in cancer care.

Target Audience

Physicians, physician assistants, nurse practitioners and allied health professionals 

Learning Objectives

Participants who engage in this educational activity will be able to:

  • Improve understanding of new systemic treatment options, including targeted therapy and immunotherapy for lung cancer
  • Improve understanding of radiation options in lung cancer
  • Improve understanding of surgical options in the treatment of lung cancer
Additional information


Dan Bullock
Phone Number: 
+1 (414) 805-4617
Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
Course expires: 
Event starts: 
08/20/2022 - 8:00am CDT
Event ends: 
08/20/2022 - 12:00pm CDT

7:30 – 8:00 a.m.                              Check-in / View Exhibits

8:30 – 9:10 a.m.                              Surgeon’s Perspective on the Management of NSCLC, Mario Gasparri, MD

9:00 – 9:40 a.m.                             Perioperative Therapy in NSCLC, Gregory Otterson MD, (James Thoracic Oncology Center)

9:40 – 10:10 a.m.                           Management of Centrally Located Tumors with Hypofractionated Radiation Regimens, Monica Shukla, MD

10:10 – 10:25 a.m.                         Break / View Exhibits

10:25 – 11:05 a.m.                         Management of KRAS Mutated Non-Small Cell Lung Cancer, Grace Dy, MD (Roswell Park Comprehensive Cancer Center)

11:05 – 11:45 a.m.                         Telemedicine for Cancer Care After the COVID-19 Pandemic , Howard West, MD (Access Hope)

11:45 - 11:55 a.m.                          Break/Lunch

11:55 a.m. – 12:25 p.m.                Management of Immunotherapy Toxicities, Jonathan Thompson, MD

12:25 - 12:55 p.m.                          Therapeutic Advancements in the Management of Advanced Small Cell Lung Cancer, Huizi Chen, MD, PhD

12:55 p.m.                                       Adjourn




Italian Community Center
631 E. Chicago Street
Milwaukee, WI 53202
United States
+1 (414) 223-2180

Free parking is available for all attendees. Access to the surface lot via the gate on Jackson Street. 

In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

Guest Speakers:

Gregory Otterson, MD
James Comprehensive Cancer Center
The Ohio State University
Howard (Jack) West, MD
Clinical Executive Director, Access Hope
Associate Clinical Professor 
City of Hope
Froedtert & Medical College of Wisconsin Speakers
Huizi Chen, MD, PhD
Assistant Professor
Division of Hematology & Oncology
Department of Medicine
Medical College of Wisconsin
Mario Gasparri, MD
Professor, Cardiothoracic Surgery
Thoracic Surgery
Medical College of Wisconsin
Monica Shukla, MD
Assistant Professor
Associate Director, Radiation Oncology Residency Program
Medical College of Wisconsin
Jonathan Thompson, MD, MS
Assistant Professor
Division of Hematology & Oncology
Medical College of Wisconsin
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.
Grace Dy, MDAmgen, Eli Lilly, Mirati, Takeda, AstraZenecaConsultant
Mario Gasparri, MDAtricure, Intuitive SurgicalConsultant
Howard West, MD  
Gregory Otterson, MD

BeiGene, AbbVie, Array Pharmaceuticals, AstraZeneca, BMS, Dizal,

Elevation Oncology, Genentech, Pfizer, Revolution Medicine



ACCME Accreditation Statement: 

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

AMA Credit Designation Statement: 

The Medical College of Wisconsin designates this for a maximum of 4.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Hours of Participation for Allied Health Care Professionals: 

The Medical College of Wisconsin designates this activity for up to 4.0 hours of participation for continuing education for allied health professionals.  

Available Credit

  • 4.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.00 Hours of Participation
    Hours of Participation credit.


Please login or register to take this course.